Medication Guide App

Prenaissance Plus

Generic Name: calcium citrate, iron pentacarbonyl, cholecalciferol, dl-alpha tocopherol acetate, pyridoxine hydrochloride, folic acid, docusate sodium and doconexent
Dosage Form: capsule, liquid filled

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Prenaissance Plus

Rx Only

DESCRIPTION:

Prenaissance Plus is a prescription prenatal/postnatal multivitamin/multimineral softgel capsule with DHA. Each softgel is purple in color, opaque and imprinted with "343" on one side.

EACH SOFTGEL CONTAINS:

Calcium (Calcium citrate) 100 mg
Iron (Carbonyl Iron) 28 mg
Vitamin D3 (Cholecalciferol) 400 IU
Vitamin E (dl-alpha tocopherol acetate) 30 IU
Vitamin B6 (Pyridoxine HCI) 25 mg
Folic Acid 1 mg
Docusate Sodium 50 mg
DHA (Docosahexaenoic acid) 250 mg

OTHER INGREDIENTS:

soybean oil, yellow bee's wax, lecithin, natural orange cream flavoring, gelatin, glycerine, purified water, carmine, titanium dioxide, ethyl vanillin, FD&C#40, and FD&C Blue #1.

INDICATIONS:

Prenaissance Plus is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers.

CONTRAINDICATIONS:

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

WARNING:

Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.

WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.

PRECAUTIONS:

Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where Vitamin B12 is deficient. Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations progress.

ADVERSE REACTIONS:

Allergic sensitization has been reported following both oral and parenteral administration of folic acid.

CAUTION:

Exercise caution to ensure that the prescribed dosage of DHA does not exceed 1 gram (1000 mg) daily.

DOSAGE AND ADMINISTRATION:

Usual adult dose is 1 (one) softgel daily or as directed by a physician.

NOTICE:

Contact the moisture can discolor or erode the capsule.

HOW SUPPLIED:

Prenaissance Plus is supplied in child-resistant bottles of 30 softgels (NDC# 42192-343-30).

Store at 15° - 30°C (59° - 86°F) [See USP].

KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

All prescription substitutions and/or recommendations using this product shall be made subject to state and federal statutes as applicable. Please note: this is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency. Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, excipients, inactive ingredients and chemical information provided herein.

MANUFACTURED FOR:
Acella Pharmaceuticals, LLC
Alpharetta, GA 30009

PRINCIPAL DISPLAY PANEL - 30 Softgels

NDC 42192-343-30

Prenaissance Plus

Rx Prenatal Vitamin and DHA

Rx only              30 Softgels

Acella
PHARMACEUTICALS, LLC

Prenaissance Plus 
calcium citrate, iron pentacarbonyl, cholecalciferol, .alpha.-tocopherol acetate, dl-, pyridoxine hydrochloride, folic acid, docusate sodium and doconexent capsule, liquid filled
Product Information
Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC:42192-343
Route of Administration ORAL DEA Schedule     
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CALCIUM CITRATE (CALCIUM CATION) CALCIUM CATION 100 mg
IRON PENTACARBONYL (IRON PENTACARBONYL) IRON PENTACARBONYL 28 mg
CHOLECALCIFEROL (CHOLECALCIFEROL) CHOLECALCIFEROL 400 [iU]
.ALPHA.-TOCOPHEROL ACETATE, DL- (.ALPHA.-TOCOPHEROL, DL-) .ALPHA.-TOCOPHEROL, DL- 30 [iU]
PYRIDOXINE HYDROCHLORIDE (PYRIDOXINE) PYRIDOXINE 25 mg
FOLIC ACID (FOLIC ACID) FOLIC ACID 1 mg
DOCUSATE SODIUM (DOCUSATE) DOCUSATE SODIUM 50 mg
DOCONEXENT (DOCONEXENT) DOCONEXENT 250 mg
Inactive Ingredients
Ingredient Name Strength
SOYBEAN OIL  
YELLOW WAX  
GELATIN  
GLYCERIN  
WATER  
TITANIUM DIOXIDE  
ETHYL VANILLIN  
FD&C RED NO. 40  
FD&C BLUE NO. 1  
Product Characteristics
Color PURPLE Score no score
Shape CAPSULE Size 25mm
Flavor Imprint Code 343
Contains         
Packaging
# Item Code Package Description
1 NDC:42192-343-30 30 CAPSULE, LIQUID FILLED in 1 CAPSULE
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
UNAPPROVED DRUG OTHER 09/12/2011
Labeler - Acella Pharmaceuticals, LLC (825380939)
Registrant - Acella Pharmaceuticals, LLC (825380939)
Establishment
Name Address ID/FEI Operations
Viva 253288898 MANUFACTURE(42192-343)
Revised: 08/2012
 
Acella Pharmaceuticals, LLC



Hide
(web5)